entocort klyzma tablet for rectal suspension 2mg - arama sonuçları

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

entocort

astrazeneca pty ltd - budesonide -

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

entocort

astrazeneca limited - budesonide 2.25mg; ; - modified release capsule - 2.25 mg - active: budesonide 2.25mg excipient: acetyl tributyl citrate ethylcellulose gelatin methacrylic acid copolymer polysorbate 80 purified talc simeticone sugar spheres triethyl citrate

ABD - İngilizce - NLM (National Library of Medicine)

entocort ec- budesonide capsule

prometheus laboratories inc - budesonide (unii: q3oks62q6x) (budesonide - unii:q3oks62q6x) - budesonide 3 mg - entocort ec is indicated for - the treatment of mild to moderate active crohn's disease involving the iluem and/or the ascending colon and - the maintenance of clinical remission of mild to moderate crohn's disease involving the ileum and/or the ascending colon for up to 3 months. the maintenance of clinical remission of mild to moderate crohn's disease involving the ileum and/or the ascending colon for up to 3 months. entocort ec is contraindicated in patients with known hypersensitivity to budesonide.